Regenerative Cell Therapies
A Regenerative Cell Therapy Program Advancing Longevity and Wellness
PLURY’s Next-Generation Regenerative Cell Therapy Program brings together advanced cellular therapies offered through licensed medical clinics in Korea and Japan. Developed with our R&D partner S.Biomedics, a global leader in stem cell research, this program provides a comprehensive approach to improving long term wellness and skin vitality.
Our program includes two core therapies, each designed to support the body at a different level: systemic wellness and personalized skin regeneration.
S.Biomedics’ Adipose Stem Cell (MSC) and Dermal Fibroblast Therapies
Autologous Adipose Stem Cell IV
Supporting whole body wellness and vitality
Autologous Adipose Stem Cell IV is a cell-based regenerative therapy approach in which stem cells extracted from the patient’s own adipose tissue are cultured and administered through intravenous infusion.
Adipose-derived mesenchymal stem cells (MSC) possess strong regenerative properties and are widely studied in regenerative medicine.
FECS CureSkin® Autologous Dermal Fibroblast Therapy
Personalized skin regeneration using your own cells
FECS CureSkin® is an autologous fibroblast therapy in which a client’s own skin cells are cultured and reinjected to support collagen activity and skin rejuvenation.
This personalized approach helps improve elasticity, firmness, texture, and the visible signs of aging by strengthening the skin’s natural cellular processes.
Interested in our cell therapies or exploring strategic partnerships?
Discover the opportunity to shape the future of regenerative cell therapies with PLURY.
